Recruiting studies: Cecal Neoplasms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Phase 2 · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT05913674 Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Phase 2 · 2 location(s) · Prakash Pandalai · NCT04779554 Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04847063 Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C M
Phase 1/Phase 2 · 53 location(s) · Revolution Medicines, Inc. · NCT06128551 Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
Phase 4 · 1 location(s) · Cedars-Sinai Medical Center · NCT07124351 Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
NA · 1 location(s) · Dartmouth-Hitchcock Medical Center · NCT05780684 Molecular Characterisation of Appendiceal Cancer
Phase N/A · 1 location(s) · The Christie NHS Foundation Trust · NCT05364788 Target-specific immunoPET Imaging of Digestive System Carcinoma
NA · 1 location(s) · RenJi Hospital · NCT06715839 Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix
Phase N/A · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT05919758 Molecular Profiling for Risk Stratification in Appendiceal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07587268 A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherap
NA · 1 location(s) · Yale University · NCT07291180 Local Cecal Cancer - Optimization of Surgical Treatment
NA · 1 location(s) · Moscow Clinical Scientific Center · NCT06121089 Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT04907643 Genetics of Appendix Cancer Study
Phase N/A · 1 location(s) · Andreana Holowatyj, PhD, MSCI · NCT05734430 PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gast
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT04329494 Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Phase 3 · 51 location(s) · Crinetics Pharmaceuticals Inc. · NCT07087054 Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
NA · 1 location(s) · University of California, Davis · NCT06101277 Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05472948 The Impact of Image-Assisted Colonoscope on Patient Experience, Physician Workload, and Examination Quality
NA · 1 location(s) · DONG WU · NCT07541924 Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
NA · 344 location(s) · Alliance for Clinical Trials in Oncology · NCT07283939 EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastroint
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT06263088

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.